Subfornical organ differentially modulates baroreflex function in normotensive and two-kidney, one-clip hypertensive rats.
During activation of the renin-angiotensin system, hindbrain circumventricular organs such as the area postrema have been implicated in modulating the arterial baroreflex. This study was undertaken to test the hypothesis that the subfornical organ (SFO), a forebrain circumventricular structure, may also modulate the baroreflex. Studies were performed in rats with two-kidney, one-clip (2K,1C) hypertension as a model of endogenously activated renin-angiotensin system. Baroreflex function was ascertained during ramp infusions of phenylephrine and nitroprusside in conscious sham-clipped and 5-wk 2K,1C rats with either a sham or electrolytically lesioned SFO. Lesioning significantly decreased mean arterial pressure in 2K,1C rats from 158 +/- 7 to 131 +/- 4 mmHg but not in sham-clipped rats. SFO-lesioned, sham-clipped rats had a significantly higher upper plateau and range of the renal sympathetic nerve activity-mean arterial pressure relationship compared with sham-clipped rats with SFO ablation. In contrast, lesioning the SFO in 2K,1C rats significantly decreased both the upper plateau and range of the baroreflex control of renal sympathetic nerve activity, but only the range of the baroreflex response of heart rate decreased. Thus, during unloading of the baroreceptors, the SFO differentially modulates the baroreflex responses in sham-clipped vs. 2K,1C rats. Since lesioning the SFO did not influence plasma angiotensin II (ANG II), the effects of the SFO lesion are not caused by changes in circulating levels of ANG II. These findings support a pivotal role for the SFO in the sympathoexcitation observed in renovascular hypertension and in baroreflex regulation of sympathetic activity in both normal and hypertensive states.
Maliszewska-Scislo
Maria
M
Dept. of Internal Medicine, Wayne State Univ. School of Medicine, 4160 John R. St., Detroit, MI 48201, USA.
Chen
Haiping
H
Augustyniak
Robert A
RA
Seth
Dale
D
Rossi
Noreen F
NF
D000804:Angiotensin II / Q000097:blood; D000818:Animals; D017704:Baroreflex / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D003714:Denervation; D004195:Disease Models, Animal; D006339:Heart Rate / Q000502:physiology; D006977:Hypertension, Renal / Q000503:physiopathology*; D007668:Kidney / Q000294:innervation* / Q000502:physiology*; D008297:Male; D009599:Nitroprusside / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013356:Subfornical Organ / Q000502:physiology*; D013525:Surgical Instruments; D013564:Sympathetic Nervous System / Q000502:physiology; D013566:Sympathomimetics / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology; D014882:Water-Electrolyte Balance / Q000502:physiology
D013566:Sympathomimetics; D014665:Vasodilator Agents; D000804:Angiotensin II; D009599:Nitroprusside; D010656:Phenylephrine
J Auton Nerv Syst. 1995 Oct 5;55(1-2):92-104
8690857
Am J Physiol. 1981 Sep;241(3):H381-8
7282947
J Physiol. 1993 Feb;461:501-11
8350273
Brain Res. 1989 Mar 27;483(1):192-5
2706508
Brain Res. 1998 Aug 10;801(1-2):239-43
9729407
Circ Res. 1990 Dec;67(6):1462-73
2245506
Brain Res. 2004 Jan 2;995(1):109-17
14644476
Exp Brain Res. 1986;62(3):509-14
3720882
Am J Physiol. 1980 Nov;239(5):R382-9
7435651
Neurosci Lett. 2004 Oct 7;369(1):14-8
15380299
Circ Res. 1984 Apr;54(4):355-66
6370491
Circ Res. 1983 Aug;53(2):223-34
6883646
Circ Res. 2003 Jun 27;92(12):1330-6
12764023
Clin Exp Pharmacol Physiol. 1997 Jan;24(1):96-101
9043813
Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1592-602
11959620
Am J Physiol. 1988 Dec;255(6 Pt 2):R961-7
3202228
Fed Proc. 1984 Jan;43(1):25-31
6360715
Hypertension. 1991 May;17(5):626-35
2022407
Am J Physiol. 1998 Nov;275(5):R1523-9
9791069
J Neuroendocrinol. 2004 Apr;16(4):340-7
15089972
Biol Signals. 1995 May-Jun;4(3):117-23
8750937
Am J Physiol Heart Circ Physiol. 2003 May;284(5):H1601-11
12521945
J Hypertens Suppl. 1986 Dec;4(5):S27-30
3471907
Am J Physiol Renal Physiol. 2007 Jul;293(1):F139-47
17376762
Am J Physiol. 1993 May;264(5 Pt 2):F891-8
8388654
J Pharmacol Exp Ther. 1994 Nov;271(2):804-10
7965799
Am J Physiol. 1993 Oct;265(4 Pt 2):H1275-82
8238414
Front Neuroendocrinol. 1997 Oct;18(4):383-439
9344632
Acta Physiol Scand Suppl. 1990;591:100-6
2220402
Am J Physiol. 1984 May;246(5 Pt 2):F620-6
6372522
Auton Neurosci. 2002 Jan 10;95(1-2):131-6
11871778
Hypertension. 2003 Dec;42(6):1124-9
14597646
Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1804-12
11009467
Proc Natl Acad Sci U S A. 1984 Mar;81(5):1575-9
6324205
Am J Physiol. 1988 May;254(5 Pt 2):R746-54
3364604
Am J Physiol. 1999 Jul;277(1 Pt 2):R56-65
10409258
Hypertension. 1987 Apr;9(4):355-61
3557601
Kidney Int. 1986 Sep;30(3):437-52
3537449
Am J Physiol. 1998 Jul;275(1):R46-55
9688959
Hypertension. 1998 Jan;31(1):68-72
9449393
Am J Physiol. 1995 Mar;268(3 Pt 2):R625-33
7900904
Am J Physiol Regul Integr Comp Physiol. 2004 Dec;287(6):R1325-34
15308489
Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R856-62
15793039
Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H680-5
15458953
Am J Physiol. 1986 Jun;250(6 Pt 2):R960-72
3521337
Appetite. 1998 Dec;31(3):309-31
9920685
Hypertension. 2003 Mar;41(3):576-82
12623962
J Cardiovasc Pharmacol. 1995;26 Suppl 2:S7-16
8642810
Neuroendocrinology. 1980 Dec;31(6):380-4
7453950